Vanda Pharmaceuticals Inc. (VNDA)
NASDAQ · Manufacturing · Pharmaceutical preparations
$5.05+$0.0700 (+1.41%) on the dayAs of the close; data may be delayed.
VNDA price, last 12 months
Key stats
- Previous close
- $4.98
- Open
- $5.01
- Day range
- $4.93 – $5.07
- 52-week range
- $4.27 – $9.94
- Volume
- 596K
- Avg volume (20 days)
- 757.6K
- Market cap
- $305.3M
Performance
1W−1.6%
1M−5.6%
3M−16.0%
6M−29.1%
YTD−42.7%
1Y+3.1%
vs S&P 500, 1Y−13.7 pts
Technicals and fundamentals
About Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include ASO Molecules, VQW-765, Tradipitant, and VTR-297. The maximum of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NASDAQ
- Market cap
- $305.3M